News Releases

Moffitt Cancer Center, Thomas Jefferson University Receive $2.8 Million to Advance Acral Melanoma Research

Collaborative project will investigate new immune and targeted treatment strategies for a rare and difficult-to-treat form of melanoma

New Treatment Scheduling Strategy May Help Cancer Drugs Stay Effective Longer

Dosing strategy aims to slow drug resistance by changing how treatments are scheduled

Moffitt Cancer Center Launches Radiopharma Program to Accelerate Research, Clinical Translation, and Manufacturing of Next Generation Cancer Treatment

New interdisciplinary program will bring together clinical, research and operational expertise to position Speros as a Southeastern hub for...

Moffitt Researchers Develop Mathematical Measures to Better Personalize Therapy for Prostate Cancer

New approach using routine PSA information may help identify patients most likely to benefit from treatment breaks

New Moffitt Study Offers Clues to Why TIL Immunotherapy Works for Some Melanoma Patients but Not Others

Findings reveal immune cell and tumor characteristics that could help researchers improve tumor-infiltrating lymphocyte therapy and identify patients...

Moffitt Scientists Pioneer Next Generation Covalent Chemistry to Build Safer Precision Medicines

New chemistry helps experimental cancer drugs target tumors more precisely while reducing unwanted interactions in preclinical studies

Moffitt Cancer Center Announces Research Alliance With Takeda To Advance Cancer Therapies

New collaboration aims to expand clinical and translational research in blood cancers and solid tumors

Moffitt Study Identifies Protein that Helps Eye Cancer Spread to the Liver

Protein alters liver cells and blood vessel growth, creating a foothold for metastasis

Forge Coalition Launches To Position Tampa Bay as Southeast Hub for Radiopharmaceutical Innovation, Training and Production

Speros Powered by Moffitt Cancer Center, Embarc Collective, University of South Florida and Pasco-Hernando State College unite to transform the...

Dr. Patrick Hwu Inducted Into Florida Inventors Hall of Fame

Moffitt Cancer Center president and CEO recognized for groundbreaking advancements in cancer immunotherapy and CAR T therapy

Moffitt Study Suggests Immunotherapy May Strengthen Treatment for Aggressive Prostate Cancer

Encouraging early findings when nivolumab is added to a radiotherapy-based regimen

How Genetic Information Keeps Cells Alive: A New Model from Moffitt Cancer Center

Framework shows how enzymes translate genetic information into physical forces that sustain life’s internal order

Moffitt Cancer Center Recognized as a Tampa Bay Times Top Workplace for the 15th Time

The cancer center honored among the top 165 workplaces in Tampa Bay area

Moffitt Cancer Center Earns 2025 Press Ganey Human Experience Guardian of Excellence Award

National honor recognizes top-performing health systems for excellence in patient experience, quality, safety and workforce engagement

Moffitt Study Identifies Distinct Tumor-Immune Ecologies That Predict Immunotherapy Response in Lung Cancer

Study shows tumor microenvironment ecology predicts response better than PD-L1 status alone